基本信息
浏览量:115
职业迁徙
个人简介
Revivicor is a regenerative medicine company, based in Blacksburg Virginia, and in conjunction with its parent company, United Therapeutics, is focused on providing a safe, human-compatible, alternative tissue source for human therapeutic use towards overcoming the World-wide organ shortage crisis. The company is developing a diverse pipeline of genetically engineered (GE) pigs for use in xenotransplantation applications, including the first FDA approved pig, GalSafeTM. In January (2022), Revivicor provided the GE pig used by the University of Maryland surgeons for the first-ever heart transplant into a patient, David Bennett, and for the LVAD+ Thymokidney transplant at NYU in April 2024.
Prior to joining PPL, Dr. Ayares worked for 7 years in the pharmaceutical industry at Abbott Laboratories and Baxter Healthcare, developing transgenic mouse models for pharmaceutical testing, as well as encapsulation technologies for islet cell delivery for treatment of diabetes.
Prior to joining PPL, Dr. Ayares worked for 7 years in the pharmaceutical industry at Abbott Laboratories and Baxter Healthcare, developing transgenic mouse models for pharmaceutical testing, as well as encapsulation technologies for islet cell delivery for treatment of diabetes.
研究兴趣
论文共 2 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
作者统计
#Papers: 2
#Citation: 30
H-Index: 2
G-Index: 2
Sociability: 1
Diversity: 1
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn